Form 8-K - Current report:
SEC Accession No. 0001104659-20-117064
Filing Date
2020-10-22
Accepted
2020-10-22 12:34:35
Documents
14
Period of Report
2020-10-17
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2030810-15_8k.htm   iXBRL 8-K 27364
2 EXHIBIT 99.1 tm2030810d15_ex99-1.htm EX-99.1 7318
6 GRAPHIC tm2030810d15_ex99-1img01.jpg GRAPHIC 2576
  Complete submission text file 0001104659-20-117064.txt   213546

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA gild-20201017.xsd EX-101.SCH 3180
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE gild-20201017_lab.xml EX-101.LAB 34591
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gild-20201017_pre.xml EX-101.PRE 22706
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2030810-15_8k_htm.xml XML 3511
Mailing Address 333 LAKESIDE DR FOSTER CITY CA 94404
Business Address 333 LAKESIDE DR FOSTER CITY CA 94404 6505743000
GILEAD SCIENCES INC (Filer) CIK: 0000882095 (see all company filings)

EIN.: 943047598 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19731 | Film No.: 201253117
SIC: 2836 Biological Products, (No Diagnostic Substances)